全文获取类型
收费全文 | 80524篇 |
免费 | 5810篇 |
国内免费 | 186篇 |
专业分类
耳鼻咽喉 | 773篇 |
儿科学 | 2985篇 |
妇产科学 | 2525篇 |
基础医学 | 10225篇 |
口腔科学 | 1014篇 |
临床医学 | 12453篇 |
内科学 | 14741篇 |
皮肤病学 | 1192篇 |
神经病学 | 7617篇 |
特种医学 | 1705篇 |
外国民族医学 | 35篇 |
外科学 | 7792篇 |
综合类 | 1359篇 |
现状与发展 | 1篇 |
一般理论 | 124篇 |
预防医学 | 10364篇 |
眼科学 | 1249篇 |
药学 | 4679篇 |
1篇 | |
中国医学 | 137篇 |
肿瘤学 | 5549篇 |
出版年
2023年 | 544篇 |
2022年 | 856篇 |
2021年 | 1709篇 |
2020年 | 1150篇 |
2019年 | 1833篇 |
2018年 | 2048篇 |
2017年 | 1464篇 |
2016年 | 1644篇 |
2015年 | 1795篇 |
2014年 | 2392篇 |
2013年 | 3903篇 |
2012年 | 5491篇 |
2011年 | 5653篇 |
2010年 | 3129篇 |
2009年 | 2885篇 |
2008年 | 4970篇 |
2007年 | 5484篇 |
2006年 | 5164篇 |
2005年 | 5065篇 |
2004年 | 4926篇 |
2003年 | 4639篇 |
2002年 | 4353篇 |
2001年 | 812篇 |
2000年 | 665篇 |
1999年 | 776篇 |
1998年 | 960篇 |
1997年 | 748篇 |
1996年 | 678篇 |
1995年 | 586篇 |
1994年 | 538篇 |
1993年 | 547篇 |
1992年 | 526篇 |
1991年 | 483篇 |
1990年 | 472篇 |
1989年 | 435篇 |
1988年 | 410篇 |
1987年 | 400篇 |
1986年 | 373篇 |
1985年 | 419篇 |
1984年 | 404篇 |
1983年 | 362篇 |
1982年 | 438篇 |
1981年 | 416篇 |
1980年 | 346篇 |
1979年 | 260篇 |
1978年 | 216篇 |
1977年 | 238篇 |
1976年 | 247篇 |
1975年 | 202篇 |
1974年 | 220篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
22.
David M Raffel Robert A Koeppe Roderick Little Chia-Ning Wang Suyu Liu Larry Junck Mary Heumann Sid Gilman 《Journal of nuclear medicine》2006,47(11):1769-1777
Scintigraphic imaging with (123)I-metaiodobenzylguanidine ((123)I-MIBG) has demonstrated extensive losses of cardiac sympathetic neurons in idiopathic Parkinson's disease (IPD). In contrast, normal cardiac innervation has been observed in (123)I-MIBG studies of multiple-system atrophy (MSA) and progressive supranuclear palsy (PSP). Consequently, it has been hypothesized that cardiac denervation can be used to differentiate IPD from MSA and PSP. We sought to test this hypothesis by mapping the distribution of cardiac sympathetic neurons in patients with IPD, MSA, and PSP by using PET and (11)C-meta-hydroxyephedrine ((11)C-HED). Also, the relationship between cardiac denervation and nigrostriatal denervation was investigated by measuring striatal presynaptic monoaminergic nerve density with PET and (11)C-dihydrotetrabenazine ((11)C-DTBZ). METHODS: (11)C-HED and (11)C-DTBZ scans were obtained for patients with IPD (n = 9), MSA (n = 10), and PSP (n = 8) and for age-matched control subjects (n = 10). Global and regional measurements of (11)C-HED retention were obtained to assess the extent of cardiac sympathetic denervation. (11)C-DTBZ binding was measured in the caudate nucleus, anterior putamen, and posterior putamen. RESULTS: As expected, extensive cardiac denervation was observed in several of the patients with IPD. However, substantial cardiac denervation was also seen in some patients with MSA and PSP. (11)C-DTBZ studies demonstrated striatal denervation in all patients with IPD and in most patients with MSA and PSP. No correlation was found between cardiac (11)C-HED retention and striatal (11)C-DTBZ binding. CONCLUSION: Cardiac sympathetic denervation was found to occur not only in IPD but also in other movement disorders, such as MSA and PSP. This finding implies that scintigraphic detection of cardiac sympathetic denervation cannot be used independently to discriminate IPD from other movement disorders, such as MSA and PSP. Cardiac sympathetic denervation was not correlated with striatal denervation, suggesting that the pathophysiologic processes underlying cardiac denervation and striatal denervation occur independently in patients with parkinsonian syndromes. These findings provide novel information about central and peripheral denervation in patients with neurodegenerative disorders. 相似文献
23.
24.
25.
26.
Mary C Tierney W Gary Snow Jocelyn Charles Rahim Moineddin Alex Kiss 《The American journal of geriatric psychiatry》2007,15(2):140-148
OBJECTIVE: The authors examined the accuracy of certain neuropsychological tests in the prediction of harm resulting from self-neglect in cognitively impaired seniors who lived alone. METHODS: The study included 130 participants, aged 65 and older, who scored less than 131 on the Dementia Rating Scale. Neuropsychological tests were administered at baseline, resulting in eight predictive scores. Informants and primary care physicians provided information about harm that occurred to the participants during the 18-month prospective follow up. An incident was defined as harmful if it occurred as the result of self-neglect or disorientation and resulted in physical injury or property loss or damage and required emergency interventions. Proportional hazard regression analysis was conducted to examine the predictive relationship between the eight neuropsychological tests and time to incident harm with age, sex, education, the Charlson Comorbidity Index, and the Mini-Mental State Examination included in the model as covariates. RESULTS: Twenty-seven participants experienced harm during the 18-month follow-up period. A proportional hazards model indicated that three neuropsychological tests, which measured recognition memory, executive functioning, and conceptualization, were independent risk factors for harm. CONCLUSIONS: These findings provide insight into why harm occurred in these cognitively impaired elders who lived alone. They also support the ecologic validity of these tests and suggest directions for the development of intervention strategies for harm prevention. 相似文献
27.
Alemtuzumab (CAMPATH 1H) Induction Therapy in Cadaveric Kidney Transplantation—Efficacy and Safety at Five Years 总被引:2,自引:0,他引:2
Christopher J. E. Watson J. Andrew Bradley Peter J. Friend John Firth Craig J. Taylor John R. Bradley Kenneth G. C. Smith Sathia Thiru Neville V. Jamieson Geoff Hale Herman Waldmann Roy Calne 《American journal of transplantation》2005,5(6):1347-1353
Alemtuzumab is a powerful lymphocyte depleting antibody currently being evaluated in solid organ transplantation. This paper describes 5-year results of a single center study of alemtuzumab as induction in renal transplantation. Thirty-three renal transplant recipients received 20 mg alemtuzumab on day 0 and 1, followed by half-dose cyclosporin monotherapy (trough concentration 75-125 ng/mL) from day 3. They were compared in a retrospective contemporaneous-controlled manner with 66 kidney transplant recipients transplanted in the same period and center who received conventional immunosuppression with cyclosporin, azathioprine and prednisolone. In the alemtuzumab group 12% of recipients died compared to 17% in the control group (p = 0.48); likewise graft loss was similar in both groups (21% vs. 26%, respectively, p = 0.58). Incidence of acute rejection was also comparable at 5 years (31.5% vs. 33.6%), although the pattern of rejection was different with 14% patients in the alemtuzumab group experiencing rejection over 1 year post-transplant compared to none in the control group. There was no significant difference between groups in terms of infection or serious adverse events. While acknowledging the limitations of a relatively small single-center study, results suggest that alemtuzumab induction allowed satisfactory long-term patient and graft survival equivalent to that seen with standard triple immunosuppression, while avoiding steroid therapy. 相似文献
28.
29.
30.